Court rules in favor of DuPont in Novozymes’ Entitlement Litigation

Danish Court confirms DuPont’s ownership of two amylase patent applications

On June 27, 2019, the Danish Maritime and Commercial Court ruled in favor of Danisco’s ownership of the innovation behind two Danisco amylase patent applications (EP2859097 and EP2825643). The court reasoned that Novozymes’ legal argument that an entitlement action could be based on prior art was without merit and awarded costs to Danisco.

DuPont™ Danisco^® is the brand for a range of products that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages and dietary supplements.

“Testimony from the trial clearly showed that the inventions claimed in these patent applications were based on Danisco technology and reflect our long history of innovation throughout the globe,” said Wayne Ashton, Global Business Director for home and personal care at DuPont.